Classic and alternative T cell p38 activation: two pathways with profoundly different biological consequences

Muhammad Alam Paul Mittelstadt Matthias Gaida Jonathan Ashwell
Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD
Like all MAPK, p38 is activated by a kinase cascade resulting in dual phosphorylation of the activation loop (Thr-180 and Tyr-182). T cells possess an additional pathway downstream of the T cell receptor (TCR), in which p38 is phosphorylated on Tyr-323 by ZAP70, leading to auto-monophosphorylation of Thr-180 (alternative pathway). We have examined the physiologic role of the alternative pathway by creating knockin mice in which p38α and p38β Tyr-323 is replaced with a Phe and thus cannot be phosphorylated by ZAP70 (DKI mice). DKI mice are resistant to diseases such as experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis. Analysis of transcription factor expression revealed that NF-ATc1 (NFAT2) and IRF-4, which are upstream of RORC and IL-17, are induced in CD4+T cells by TCR stimulation but not PMA and ionomycin, a stimulus that activates the classic MAPK cascade and is widely used to mimic TCR signaling. Consistent with this, induction of these proteins was markedly reduced in DKI CD4+T cells that lack the alternative pathway. Notably, activation of the classic p38 MAPK cascade by stress (UV irradiation or osmotic shock) abrogated TCR-mediated upregulation of NF-ATc1, IRF-4, and IL-17. When introduced in the gut of wild type mice, C. rodentium (citrobacter) induce an IL-17-dependent immune response that results in clearance of the pathogen. DKI mice, however, failed to mount an IL-17 response and did not eradicate the bacteria. Thus, TCR-mediated monophosphorylation of p38 is essential for IL-17 production, which is inhibited by its dual phosphorylation via the MAPK cascade.








Powered by Eventact EMS